Pink Biopharma is a drug-discovery company that is developing a therapeutic monoclonal antibody as a natural-killer immune checkpoint inhibitor for a variety of cancers, specifically acute myeloid leukemia.
The company is a portfolio company of the FutuRx biotech incubator.